Thomas Shrader
Stock Analyst at BTIG
(4.30)
# 1,314
Out of 4,356 analysts
726
Total ratings
41.1%
Success rate
8.5%
Average return
Main Sectors:
Stocks Rated by Thomas Shrader
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GANX Gain Therapeutics | Maintained: Buy | $5 | $1.95 | +156.41% | 29 | May 26, 2026 | |
| IVVD Invivyd | Maintained: Buy | $10 | $1.14 | +777.19% | 5 | May 26, 2026 | |
| NTHI NeOnc Technologies Holdings | Rated: Buy | $15 | $4.64 | +223.28% | 2 | May 26, 2026 | |
| CMPS COMPASS Pathways | Maintained: Buy | $14 | $13.06 | +7.20% | 14 | May 13, 2026 | |
| ANRO Alto Neuroscience | Maintained: Buy | $28 | $20.07 | +39.51% | 7 | May 13, 2026 | |
| BIOA BioAge Labs | Initiated Coverage: Buy | $40 | $17.29 | +131.35% | 1 | May 13, 2026 | |
| HROW Harrow | Maintained: Buy | $63 | $35.21 | +78.93% | 10 | May 12, 2026 | |
| DNLI Denali Therapeutics | Maintained: Buy | $39 | $21.04 | +85.36% | 37 | May 11, 2026 | |
| STOK Stoke Therapeutics | Maintained: Buy | $39 | $30.91 | +26.17% | 30 | May 11, 2026 | |
| BIIB Biogen | Maintained: Hold | n/a | $196.00 | - | 50 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $4.36 | +175.23% | 4 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $2.16 | +177.78% | 25 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.60 | +207.69% | 29 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $202.87 | $123.46 | +64.32% | 6 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $2.73 | +46.52% | 17 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $4.42 | +465.61% | 12 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.75 | +414.29% | 33 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.66 | +200.75% | 7 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $4.82 | +231.95% | 24 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $7.92 | +190.40% | 10 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $89 | $51.40 | +73.15% | 26 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $10.97 | +73.20% | 7 | Jan 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $11.01 | +45.32% | 28 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.41 | - | 32 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $200 | $10.99 | +1,719.84% | 7 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $6.21 | n/a | 1 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $3.13 | n/a | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.66 | n/a | 14 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $0.000001 | n/a | 6 | Mar 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $1.26 | n/a | 16 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.01 | n/a | 5 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $66.26 | n/a | 20 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 → $15 | $6.91 | n/a | 10 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.42 | n/a | 5 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.91 | n/a | 15 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $216 | $11.05 | n/a | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $87 → $13 | $3.93 | n/a | 5 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 → $12 | $4.16 | n/a | 8 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.78 | n/a | 4 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $16.44 | n/a | 2 | Mar 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 | $11.88 | n/a | 4 | Mar 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $57 → $70 | $25.34 | n/a | 5 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.68 | n/a | 4 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $21.90 | n/a | 7 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 7 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $6.97 | n/a | 5 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $8.69 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.000001 | n/a | 3 | Jul 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.5 | $1.01 | n/a | 4 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.25 | n/a | 9 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.87 | n/a | 8 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.00 | n/a | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $29.23 | n/a | 1 | Oct 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $39 | $4.34 | n/a | 12 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $26 | $7.54 | n/a | 4 | Nov 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $12 | $33.35 | n/a | 4 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $40 | $11.45 | n/a | 5 | Oct 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $76 | $55.67 | n/a | 3 | Oct 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.31 | n/a | 17 | Oct 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $110 → $130 | $7.17 | n/a | 7 | Oct 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $19.07 | n/a | 2 | Jul 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 | $0.0142 | n/a | 1 | Jun 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $38 | $6.93 | n/a | 9 | Jun 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.2 → $11 | $3.81 | n/a | 4 | Dec 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $134.43 | n/a | 1 | Mar 23, 2015 |
Gain Therapeutics
May 26, 2026
Maintained: Buy
Price Target: $5
Current: $1.95
Upside: +156.41%
Invivyd
May 26, 2026
Maintained: Buy
Price Target: $10
Current: $1.14
Upside: +777.19%
NeOnc Technologies Holdings
May 26, 2026
Rated: Buy
Price Target: $15
Current: $4.64
Upside: +223.28%
COMPASS Pathways
May 13, 2026
Maintained: Buy
Price Target: $14
Current: $13.06
Upside: +7.20%
Alto Neuroscience
May 13, 2026
Maintained: Buy
Price Target: $28
Current: $20.07
Upside: +39.51%
BioAge Labs
May 13, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $17.29
Upside: +131.35%
Harrow
May 12, 2026
Maintained: Buy
Price Target: $63
Current: $35.21
Upside: +78.93%
Denali Therapeutics
May 11, 2026
Maintained: Buy
Price Target: $39
Current: $21.04
Upside: +85.36%
Stoke Therapeutics
May 11, 2026
Maintained: Buy
Price Target: $39
Current: $30.91
Upside: +26.17%
Biogen
Apr 20, 2026
Maintained: Hold
Price Target: n/a
Current: $196.00
Upside: -
Apr 6, 2026
Maintained: Buy
Price Target: $12
Current: $4.36
Upside: +175.23%
Apr 2, 2026
Maintained: Buy
Price Target: $6
Current: $2.16
Upside: +177.78%
Apr 2, 2026
Maintained: Buy
Price Target: $8
Current: $2.60
Upside: +207.69%
Mar 30, 2026
Maintained: Buy
Price Target: $202.87
Current: $123.46
Upside: +64.32%
Mar 26, 2026
Maintained: Buy
Price Target: $4
Current: $2.73
Upside: +46.52%
Mar 24, 2026
Maintained: Buy
Price Target: $25
Current: $4.42
Upside: +465.61%
Mar 17, 2026
Maintained: Buy
Price Target: $9
Current: $1.75
Upside: +414.29%
Mar 16, 2026
Maintained: Buy
Price Target: $8
Current: $2.66
Upside: +200.75%
Mar 16, 2026
Maintained: Buy
Price Target: $16
Current: $4.82
Upside: +231.95%
Mar 3, 2026
Maintained: Buy
Price Target: $23
Current: $7.92
Upside: +190.40%
Mar 2, 2026
Maintained: Buy
Price Target: $89
Current: $51.40
Upside: +73.15%
Jan 20, 2026
Maintained: Buy
Price Target: $19
Current: $10.97
Upside: +73.20%
Nov 17, 2025
Maintained: Buy
Price Target: $16
Current: $11.01
Upside: +45.32%
Nov 3, 2025
Maintained: Hold
Price Target: n/a
Current: $1.41
Upside: -
Jul 21, 2025
Maintained: Buy
Price Target: $8 → $200
Current: $10.99
Upside: +1,719.84%
May 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $6.21
Upside: n/a
Mar 4, 2025
Maintained: Buy
Price Target: $9
Current: $3.13
Upside: n/a
Mar 2, 2025
Maintained: Hold
Price Target: n/a
Current: $9.66
Upside: n/a
Mar 19, 2024
Maintained: Buy
Price Target: $32
Current: $0.000001
Upside: n/a
Feb 28, 2024
Maintained: Buy
Price Target: $33
Current: $1.26
Upside: n/a
Jan 5, 2024
Maintained: Buy
Price Target: n/a
Current: $1.01
Upside: n/a
Nov 17, 2023
Rated: Hold
Price Target: n/a
Current: $66.26
Upside: n/a
Nov 14, 2023
Rated: Buy
Price Target: $32 → $15
Current: $6.91
Upside: n/a
Aug 4, 2023
Rated: Hold
Price Target: n/a
Current: $5.42
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $4.91
Upside: n/a
Apr 3, 2023
Maintained: Buy
Price Target: $216
Current: $11.05
Upside: n/a
Mar 27, 2023
Maintained: Buy
Price Target: $87 → $13
Current: $3.93
Upside: n/a
Mar 20, 2023
Rated: Buy
Price Target: $50 → $12
Current: $4.16
Upside: n/a
Mar 20, 2023
Reiterated: Hold
Price Target: n/a
Current: $4.78
Upside: n/a
Mar 12, 2023
Rated: Buy
Price Target: $20
Current: $16.44
Upside: n/a
Mar 5, 2023
Maintained: Buy
Price Target: $56
Current: $11.88
Upside: n/a
Mar 2, 2023
Rated: Buy
Price Target: $57 → $70
Current: $25.34
Upside: n/a
Oct 15, 2021
Rated: Hold
Price Target: n/a
Current: $0.68
Upside: n/a
Oct 15, 2021
Rated: Hold
Price Target: n/a
Current: $21.90
Upside: n/a
Oct 15, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Sep 9, 2021
Rated: Buy
Price Target: $16
Current: $6.97
Upside: n/a
Aug 6, 2021
Maintained: Buy
Price Target: $60
Current: $8.69
Upside: n/a
Jul 6, 2021
Rated: Buy
Price Target: $10
Current: $0.000001
Upside: n/a
Jun 10, 2021
Maintained: Buy
Price Target: $5.5
Current: $1.01
Upside: n/a
Jun 4, 2021
Rated: Hold
Price Target: n/a
Current: $1.25
Upside: n/a
May 10, 2021
Maintained: Hold
Price Target: n/a
Current: $3.87
Upside: n/a
Sep 23, 2020
Downgraded: Hold
Price Target: n/a
Current: $1.00
Upside: n/a
Oct 6, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $29.23
Upside: n/a
Nov 9, 2017
Reiterated: Buy
Price Target: $57 → $39
Current: $4.34
Upside: n/a
Nov 7, 2017
Maintained: Buy
Price Target: $32 → $26
Current: $7.54
Upside: n/a
Nov 1, 2017
Reiterated: Buy
Price Target: $14 → $12
Current: $33.35
Upside: n/a
Oct 17, 2017
Reiterated: Buy
Price Target: $20 → $40
Current: $11.45
Upside: n/a
Oct 10, 2017
Reiterated: Buy
Price Target: $35 → $76
Current: $55.67
Upside: n/a
Oct 5, 2017
Reiterated: Buy
Price Target: $11
Current: $1.31
Upside: n/a
Oct 2, 2017
Rated: Buy
Price Target: $110 → $130
Current: $7.17
Upside: n/a
Jul 24, 2017
Reiterated: Buy
Price Target: $24
Current: $19.07
Upside: n/a
Jun 30, 2017
Downgraded: Hold
Price Target: $6
Current: $0.0142
Upside: n/a
Jun 21, 2017
Maintained: Buy
Price Target: $32 → $38
Current: $6.93
Upside: n/a
Dec 22, 2016
Reiterated: Hold
Price Target: $1.2 → $11
Current: $3.81
Upside: n/a
Mar 23, 2015
Downgraded: Hold
Price Target: n/a
Current: $134.43
Upside: n/a